6. aminoglycosides
Upcoming SlideShare
Loading in...5
×
 

6. aminoglycosides

on

  • 1,174 views

 

Statistics

Views

Total Views
1,174
Views on SlideShare
1,174
Embed Views
0

Actions

Likes
1
Downloads
49
Comments
1

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

6. aminoglycosides 6. aminoglycosides Presentation Transcript

  • Aminoglycosides Tetra cyclines Macrolids Chloramphenicol
  •  Structure Glycosidic Aminosugar - O - Aminocyclitol 2-deoxystreptamine - O- Aminosugar Streptomycin Streptidine - O - Strepose aminosugar - O - N-methyl-Lglucosamine aminosugar Streptobiosamine
  • Aminoglycosides Penetrate Bact. Cell Wall To Periplasmic Space Transport Across Cytoplasmic Membrane (Oxygen Dependent) Bind To 30s Ribosomal Units Prevent Formation of ‘Initiation Complex’ Misreading of Genetic Code on mRNA Incorrect Amino Acids into Peptide Chain Inhibits Protein Synthesis
  •  All derived from an actinomycete or are semisynthetic derivatives  Bactericidal  Are  action highly polar compounds GIT poor absorption so IV/IM  More active in alkaline pH
  • • STREPTOMYCIN (1944) • KANAMYCIN (1957 ) • GENTAMICIN (1964) • AMIKACIN • SISOMICIN • NEOMYCIN • NEITILMICIN • FRAMYCETIN • TOBRAMYCIN 1967
  •  Suffix-“Mycin”- Streptomyces  “Micin’-Micromonospora
  •  Half life 1-3hr.  Concentration  Single depended killing daily dose result in higher tissue concentration  Interval 8-12hr
  • 1. Plasmid Mediated Bacterial Transferase Enzymes 2. Deletion of Porin Channels 3. Alteration of Receptor Protein on 30s Ribosomal Unit
  • • Very Poor Oral Bioavailability • Poor Distribution • Do Not Cross BBB • Excreted Through Kidney • Excretion is directly proportion to creatine clearence
  • • AEROBIC G-ve BACILLI • ENTEROBACTERIACEAE • NOT EFFECTIVE AGAINST : G +ve BACILLI G –ve COCCI ANAEROBES
  • OTOTOXICITY:AG causes impairment of 8th cranial nerve., accumulate in the endolymph and perilymph of the inner ear leading to vestibular and cochlear damage. • Irrversible NEUROMUSCULAR BLOCKADE
  • NEPHROTOXICITY Inhibition of intracellular Phospholipase A2 in renal brush border Leads to lysosomal distension ,rapture Release acid hydrolases & AG Free drug binds to other cellular organelles Leading to degeneration and necrosis
  •  Spectrum : Y. Pestis, Brucella, F.Tularensis, M.Tuberculosis   TOXICITY : Vestibular > Auditory Lowest Nephrotoxicity USES : • • • • Tuberculosis SABE Plague Tularemia & Brucellosis
  •    Spectrum : Pseudomonas, Proteus, E. Coli, Klebsiella, Enterobacteria & Seretia. TOXICITY : More Nephrotoxic USES : • Respiratory Infection in Critically Ill Pt. • Pelvic Infection • SABE • UTIs • Pseudomonal Infections • Infected Wounds, Burns, & Conjunctivitis
  •  Clinically & PK similar to Gentamicin  Susceptible to Aminoglycoside Inactivating Enzymes  Used Interchangeably with Gentamicin
  •  Semi synthetic Derivative of SISOMYCIN  Resistant to Inactivating Enzymes  Lesser Ototoxicity  Used in Gentamicin Resistant Infections
  •  Identical To Gentamicin  2-4 times More Active Against Pseudomonas & Proteus  Ototoxicity & Nephrotoxicity < Gentamicin  Reserve Alternative to ‘G’
  •  RESISTANT TO BACTERIAL ENZYMES  USED against Gentamicin & Tobramycin Resistant Infections  USES: • Multi drug Resistant TB • Hospital Acquired Infections  Hearing loss > Vestibular loss
  •  HIGHLY TOXIC  UESE • Infected Wounds, Ulcers, Burn • External Ear & Eye Infections • Preoperative Intestinal Antiseptic • Hepatic Coma